Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Prokinetic and analgesic benzamides developed at French laboratory

March 5, 1999

Antiulcer PGE analogues developed at Taisho

March 5, 1999

Rebetol combination therapy recommended for approval in E.U.

March 2, 1999

Botulinum toxin compared to pneumatic dilatation in patients with achalasia

March 1, 1999

Positive ribavirin study results reported in the Journal of Hepatology

March 1, 1999

InKine schedules pre-NDA meeting with FDA for INKP-100

Feb. 26, 1999

Eradication of H. pylori may prevent long-term NSAID-related ulcers

Feb. 26, 1999

Healing of severe esophagitis linked to improvement in peristaltic dysfunction

Feb. 25, 1999

Axcan and Labopharm to develop controlled-release trimebutine formulation

Feb. 25, 1999

Ribozyme issued U.S. patent for ribozyme HCV therapeutics

Feb. 23, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...